Larouche G, Denault A, Prénovault J
Department of Pharmacy, Centre hospitalier de l'Université de Montréal, Quebec, Canada.
Pharmacotherapy. 2000 Nov;20(11):1396-9. doi: 10.1592/phco.20.17.1396.34897.
A woman with acute leukemia receiving induction chemotherapy with conventional doses of cytarabine (ARA-C) 200 mg/m2/day and daunorubicin 45 mg/m2/day developed acute respiratory distress syndrome. Respiratory failure was attributed to ARA-C primarily by exclusion and radiographic findings. She was weaned rapidly from the ventilator after receiving steroid therapy.